The Immunophotonics team had the privilege of volunteering at the World Wide Technology American Cancer Society Hope Lodge in St. Louis, Missouri. We spent part of the evening baking cookies and brownies for cancer patients and their caregivers. This experience was deeply meaningful for all of us. We are incredibly grateful to the patients and...
A Heartfelt Thank You to Our Event Attendees. We extend our gratitude to everyone who attended our event last night. Your support means the world to us! We would also like to express our appreciation to our esteemed guest speakers: Prof. Louis Liou, Prof. Constantinos “Costi” Sofocleous, and Prof. Wei R. Chen, who generously took...
Immunophotonics is thrilled to share that Dr. Theresa Visarius from Immunophotonics Switzerland (IPS Biopharma AG) will be presenting at the Swiss Biotech Days 2025 in Basel, Switzerland, on May 6th. Join her in room Montreal at 15:45 in the Clinical Stage Companies Session to hear about our Tumor-Specific Immune Activation to Prevent Cancer Recurrence.
Immunophotonics is excited to share that Dr. Theresa Visarius, VP Business Development will be attending the LSX World Congress Europe in London, April 28-30. This is a great opportunity to meet Theresa personally and hear how our phase 2 clinical stage asset, IP-001, provides a unique solution to combat solid tumor cancers and prevent their...
Tomas Hode, PhD, CIO & President will be attending the American Association of Cancer Research (AACR) annual meeting April 25-30, 2025, at the McCormick Place Convention Center in Chicago, IL. This pivotal event brings together scientists, clinicians, healthcare professionals, survivors, patients, and advocated to share and discuss the latest advancements in innovative cancer research and...
Immunophotonics, Inc. has strengthened its leadership team with the appointment of Jacqueline Hess to its Board of Directors. With over 30 years of experience in leading and advising heavily regulated businesses that leverage the trans-Atlantic corridor as part of their growth journey, Ms. Hess joins an already-robust slate of directors currently serving on the Board...
Diane Beatty, PhD, VP of Regulatory and Clinical Affairs, and Kelly Porterfield, Director of Clinical Operations, will be participating in the European Conference on Interventional Oncology (ECIO) in Rotterdam, Netherlands, from April 13 to 16. They will be accompanied by Lu Alleruzzo, CEO, and Tomas Hode, PhD, CIO & President. This prestigious event is one...
Lu Alleruzzo, CEO and Tomas Hode, PhD, President & CIO were honored to be invited to present at the Entrepreneurial Seminar Series hosted by The University of Oklahoma Stephenson School of Biomedical Engineering. Their presentation titled “Development and Commercialization of a Novel Immunostimulant in Combination with Local Ablation for the Treatment of Metastatic Cancers” will...
Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics will be attending the AngioDynamics International Life Symposium from March 27th to 29th in Barcelona, Spain. This symposium unites industry partners and clinical experts from around the world, featuring diverse backgrounds, skills, and ideas, all aimed at exploring the latest breakthrough technologies in interventional oncology. Be...
Lu Alleruzzo, CEO and Robert Arch, SVP Corporate Development at Immunophotonics, Inc. are attending the MedInvest Biotech and Pharma Investor conference which will be held on March 27 – 28, in New York City. Lu Alleruzzo and Robert Arch are presenting on March 27th at 12:25 pm. See how Immunophotonics is pioneering efforts that aim to...
